Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis C (HCV) Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 412 of 412 total samples
 (0)
Checkout
Advanced Data View:
Showing 412 of 412 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Detail 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Information 5Additional Data 5Additional Detail 5Additional Information 6Additional Data 6Additional Detail 6Additional Information 7Additional Data 7Additional Detail 7ICD10 codes
DLS12-0191Hepatitis C (HCV)ItalySerum1.002.00$65.0075 YFU/A<-70°C09-Aug-12Abbott Realtime PCR 6,140,000 IU/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental Care SurgerySymptomsFatigueAdditional TestingALT: 60 AST: 87 Bilirubin: 0.8 Serum Creatinine: 0.84 mg/dL Liver Disease Diagnosis: 1995 Chronic Hepatitis Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0377Hepatitis C (HCV)ItalyK2 EDTA Plasma1.001.00$65.0057 YMU/A<-70°C19-Jul-12Abbott Realtime PCR 653 IU/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgery SymptomsFatigue; JaundiceAdditional TestingALT: 20; AST: 43; ALP: 300; LDH: 349; Bilirubin: 1.59; Serum Creatinine: 1.02 mg/dL; Liver Disease Diagnosis: 2005; Hepatic CirrhosisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0385Hepatitis C (HCV)ItalyK2 EDTA Plasma1.002.00$65.0068 YFU/A<-70°C24-Jul-12Abbott Realtime PCR HCV/RNA PositiveHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgery SymptomsFatigueAdditional TestingALT: 26; AST: 33; ALP: 48; LDH: 386; Bilirubin: 0.83; Serum Creatinine: 0.82 mg/dL; Liver Disease Diagnosis: 1983; Hepatocellular Carcinoma 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0410Hepatitis C (HCV)ItalyPlasma1.005.00$85.0073 YMWhite<-70°C11-Sep-12Abbott Realtime PCR 21,196 IU/mLSiemens TruGene HCV1b$85.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsFatigueAdditional TestingALT: 46; AST: 33; ALP: 44; LDH: 237; Bilirubin: 1.24; Serum Creatinine: 0.85 mg/dL; Chronic HepatitisHepatitis Serology Resultanti-HCV+; anti-HBe+; HBeAg- (Abbott)
DLS13-03202Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0047 YMU/A<-70°C09-Dec-03Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03203Hepatitis C (HCV)SpainCitrated Plasma1.007.00$30.0039 YMU/A<-70°C17-Oct-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03204Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0042 YMU/A<-70°C20-Feb-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03206Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0039 YFU/A<-70°C18-Mar-05Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(3+)hSOD ResultsNegative
DLS13-03207Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0035 YFU/A<-70°C06-Mar-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(1+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03210Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0037 YMU/A<-70°C15-Mar-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03211Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0052 YFU/A<-70°C19-Apr-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03212Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0027 YFU/A<-70°C04-Mar-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03214Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0049 YFU/A<-70°C03-Oct-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03215Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0035 YFU/A<-70°C03-May-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03217Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0045 YMU/A<-70°C14-May-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03218Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0040 YMU/A<-70°C21-May-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03219Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0053 YMU/A< -70C01-Feb-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03220Hepatitis C (HCV)SpainCitrated Plasma1.006.00$30.0042 YFU/A< -70C26-Sep-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03222Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0040 YFU/A< -70C08-Sep-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03223Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0054 YMU/A< -70C18-Nov-03Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03224Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0031 YFU/A< -70C15-Oct-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03226Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0037 YMU/A< -70C04-Mar-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(1+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03227Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0037 YMU/A< -70C14-Jun-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03228Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0025 YMU/A< -70C06-Apr-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03229Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0043 YMU/A< -70C13-May-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03230Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0035 YMU/A< -70C20-Sep-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(-) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03231Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0034 YFU/A< -70C04-Oct-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03232Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0040 YFU/A< -70C06-Jul-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(1+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03233Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0038 YFU/A< -70C20-Aug-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03234Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0052 YFU/A< -70C30-Aug-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03235Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0035 YMU/A< -70C20-Jul-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03236Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0031 YMU/A< -70C23-Apr-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03240Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0041 YMU/A< -70C07-Jan-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03241Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0060 YFU/A< -70C05-May-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(2+)hSOD ResultsNegative
DLS13-03242Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0038 YFU/A< -70C10-Jan-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03243Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0055 YFU/A< -70C23-Sep-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03245Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0041 YFU/A< -70C12-May-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03246Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0040 YFU/A< -70C11-Mar-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03247Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0037 YMU/A< -70C24-Apr-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03248Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0034 YMU/A< -70C12-Feb-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNANegative$30.00HCV RIBA Patternc100(4+) c33(4+) c22(2+) NS5(-)hSOD ResultsNegative
DLS13-03249Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0034 YMU/A< -70C12-Jul-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03250Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0059 YMU/A< -70C11-Mar-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03251Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0059 YFU/A< -70C11-Mar-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(2+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03252Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0041 YMU/A< -70C12-Apr-09Chiron HCV RIBAPositiveAbbott PRISM7.75 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03255Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0051 YFU/A< -70C12-May-10Chiron HCV RIBAPositiveAbbott PRISM5.85 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(3+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03256Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0049 YMU/A< -70C05-Jan-08Chiron HCV RIBAPositiveAbbott PRISM10.54 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03257Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0062 YMU/A< -70C02-Jul-10Chiron HCV RIBAPositiveAbbott PRISM6.05 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03258Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0050 YMU/A< -70C27-Feb-08Chiron HCV RIBAPositiveAbbott PRISM9.69 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03259Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0019 YFU/A< -70C29-Jan-10Chiron HCV RIBAPositiveAbbott PRISM6.66 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03260Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0024 YMU/A< -70C10-Jan-08Chiron HCV RIBAPositiveAbbott PRISM8.37 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(2+) NS5(-)hSOD ResultsNegative
DLS13-03261Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0043 YMU/A< -70C06-Feb-08Chiron HCV RIBAPositiveAbbott PRISM8.08 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03262Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0057 YMU/A< -70C25-Jun-10Chiron HCV RIBAPositiveAbbott PRISM6.35 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03263Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0050 YFU/A< -70C28-Jan-08Chiron HCV RIBAPositiveAbbott PRISM5.47 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03264Hepatitis C (HCV)SpainCitrated Plasma1.006.00$30.0033 YMU/A< -70C22-Jul-10Chiron HCV RIBAPositiveAbbott PRISM5.63 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(3+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03265Hepatitis C (HCV)SpainCitrated Plasma1.002.00$30.0044 YMU/A< -70C27-Jun-10Chiron HCV RIBAPositiveAbbott PRISM6.67 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(-) c33(2+) c22(3+) NS5(-)hSOD ResultsNegative
DLS13-03266Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0027 YMU/A< -70C13-Nov-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(-) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03267Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0037 YMU/A< -70C29-May-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(2+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03270Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0035 YMU/A< -70C21-Nov-07Chiron HCV RIBAPositiveAbbott PRISM9.63 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03271Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0049 YMU/A< -70C17-Mar-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03272Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0048 YFU/A< -70C11-Apr-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03273Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0054 YMU/A< -70C24-Jan-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNANegative$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03274Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0030 YMU/A< -70C21-Dec-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03275Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0029 YMU/A< -70C09-Dec-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03276Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0051 YFU/A< -70C17-Nov-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(2+)hSOD ResultsNegative
DLS13-03277Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0062 YFU/A< -70C26-Apr-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03279Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0035 YMU/A< -70C08-Feb-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03282Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0040 YFU/A< -70C13-Dec-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03283Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0061 YMU/A< -70C03-Feb-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03284Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0043 YMU/A< -70C31-May-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03285Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0039 YMU/A< -70C25-Nov-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03287Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0044 YMU/A< -70C02-Dec-06Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03288Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0054 YMU/A< -70C23-Oct-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03290Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0038 YMU/A< -70C30-Nov-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03291Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0028 YFU/A< -70C20-Nov-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(-) c33(4+) c22(4+) NS5(2+)hSOD ResultsNegative
DLS13-03292Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0045 YMU/A< -70C16-Aug-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03293Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0042 YFU/A< -70C27-May-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03294Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0018 YFU/A< -70C18-Apr-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03295Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0043 YFU/A< -70C03-Sep-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03296Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0053 YFU/A< -70C03-Jan-05Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03297Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0024 YMU/A< -70C18-Sep-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNANegative$30.00HCV RIBA Patternc100(2+) c33(+/-) c22(3+) NS5(+/-)hSOD ResultsNegative
DLS13-03299Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0059 YFU/A< -70C05-Apr-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(2+)hSOD ResultsNegative
DLS13-03300Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0041 YMU/A< -70C21-Mar-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03301Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0040 YMU/A< -70C04-Oct-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03302Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0032 YMU/A< -70C04-Apr-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03303Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0042 YFU/A< -70C28-Nov-07Chiron HCV RIBAPositiveAbbott PRISM5.95 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03304Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0045 YMU/A< -70C17-Oct-04Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03305Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0038 YFU/A< -70C26-Mar-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03306Hepatitis C (HCV)SpainCitrated Plasma1.006.00$30.0059 YFU/A< -70C29-Jan-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(3+) c33(2+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03307Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0038 YMU/A< -70C02-Feb-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03308Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0041 YMU/A< -70C26-May-07Chiron HCV RIBAPositiveAbbott PRISMPositiveHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03309Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0028 YMU/A< -70C20-Nov-10Chiron HCV RIBAPositiveAbbott PRISM7.48 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03310Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0049 YFU/A< -70C30-Nov-11Chiron HCV RIBAPositiveAbbott PRISM1.73 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(2+) c33(2+) c22(2+) NS5(-)hSOD ResultsNegative
DLS13-03311Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0038 YMU/A< -70C13-Feb-12Chiron HCV RIBAPositiveAbbott PRISM6.9 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03313Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0059 YFU/A< -70C22-Dec-11Chiron HCV RIBAPositiveAbbott PRISM1.12 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(3+) c33(2+) c22(-) NS5(-)hSOD ResultsNegative
DLS13-03314Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0041 YMU/A< -70C10-Dec-11Chiron HCV RIBAPositiveAbbott PRISM8.53 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03315Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0039 YFU/A< -70C02-Apr-12Chiron HCV RIBAPositiveAbbott PRISM3.69 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(2+) c33(3+) c22(1+) NS5(-)hSOD ResultsNegative
DLS13-03316Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0038 YMU/A< -70C13-Nov-10Chiron HCV RIBAPositiveAbbott PRISM8.15 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(2+) c33(4+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03317Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0044 YMU/A< -70C04-Oct-11Chiron HCV RIBAPositiveAbbott PRISM7.57 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(+/-) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03318Hepatitis C (HCV)SpainCitrated Plasma1.005.00$30.0025 YMU/A< -70C14-Jan-11Chiron HCV RIBAPositiveAbbott PRISM5.4 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(2+)hSOD ResultsNegative
DLS13-03319Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0047 YMU/A< -70C13-Sep-11Chiron HCV RIBAPositiveAbbott PRISM2 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(2+) c33(2+) c22(3+) NS5(4+)hSOD ResultsNegative
DLS13-03320Hepatitis C (HCV)SpainCitrated Plasma1.006.00$30.0057 YFU/A< -70C09-Oct-03Chiron HCV RIBAPositiveAbbott PRISMPositive$30.00HCV RIBA Patternc100(2+) c33(1+) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-03321Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0029 YF< -70C20-Nov-10Chiron HCV RIBAPositiveAbbott PRISM6.09 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(-)hSOD ResultsNegative
DLS13-03322Hepatitis C (HCV)SpainCitrated Plasma1.003.00$30.0033 YM< -70C20-Nov-10Chiron HCV RIBAPositiveAbbott PRISM8.35 S/CoHCV RNAPositive$30.00HCV RIBA Patternc100(4+) c33(4+) c22(4+) NS5(4+)hSOD ResultsNegative
DLS13-03323Hepatitis C (HCV)SpainCitrated Plasma1.004.00$30.0030 YF< -70C05-Aug-11Chiron HCV RIBAPositiveAbbott PRISM2.41 S/CoHCV RNANegative$30.00HCV RIBA Patternc100(4+) c33(+/-) c22(4+) NS5(+/-)hSOD ResultsNegative
DLS13-05039Hepatitis C (HCV)VietnamK2 EDTA Plasma1.0012.00$65.0033 YMAsian< -70C11-Jun-13Roche cobas137,000 IU/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 33 U/L; AST: 23 U/L; Bilirubin: 11.5 umol/L; Serum Creatinine: 90 umol/L Hepatitis SerologyHBsAg- (ECLIA Cobas 6000)
DLS13-05043Hepatitis C (HCV)VietnamPlasma1.003.00$85.0024 YMAsian< -70C06-Jun-13Roche cobas71,800 IU/mL (HCV RNA); 195,000 (HBV RNA)Real-Time PCR1$85.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Jaundice; ItchingAdditional TestingALT: 178; AST: 138; Bilirubin: 57.9 umol/L; Serum Creatinine: 69 umol/L; Hepatitis C & BHepatitis Serology ResultHBsAg+; Anti HCV+ (ECLIA Cobas 6000)Co-InfectionsHBV+
DLS13-05065Hepatitis C (HCV)VietnamSerum1.0011.00$65.0035 YMAsian< -70C24-Jul-13Roche cobas1,180,000 IU/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigue; Abdominal pain; JaundiceAdditional TestingALT: 153 U/L; AST: 163 U/L; Bilirubin: 17 umol/L; Serum Creatinine: 95 umol/L Co-InfectionsHIV+2004
DLS13-09600Hepatitis C (HCV)VietnamSerum1.0010.00$95.0034 YMAsian< -70C06-Dec-13Roche cobas70,000,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 115 U/L; AST: 66 U/L; Serum Creatinine: 81 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2013
DLS13-09603Hepatitis C (HCV)VietnamSerum1.008.00$65.0032 YMAsian< -70C21-Nov-13Roche cobas19,700,000 copies/mLHCV$65.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg Lamivudine 150 mg Nevirapine 200 mgAcquired Infection CategoryUnknown SymptomsNo symptomsAdditional TestingALT: 25 U/L; AST: 29 U/L; Bilirubin: 7.2 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS13-09646Hepatitis C (HCV)VietnamPlasma1.0015.00$95.0030 YMAsian< -70C26-Dec-13Roche cobas7,150,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsAsymptomaticAdditional TestingALT: 93 U/L; AST: 77 U/L; Serum Creatinine: 72 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS13-11764Hepatitis C (HCV)VietnamPlasma1.0012.00$95.0035 YMAsian< -70C23-Dec-13Roche cobas2,360,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 46 U/L; AST: 48 U/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS13-11831Hepatitis C (HCV)ItalyPlasma1.001.00$85.0058 YMWhite< -70C27-Nov-13Roche cobas8,820 IU/mL (HBV); 207,000 IU/mL (HCV)PCR Sequencing; Siemens TruGene HCVD (HBV); 1b (HCV)$85.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual transmissionSymptomsFatigue Additional TestingALT: 81; AST: 37; LDH: 383; Bilirubin: 0.6; Serum Creatinine: 0.7 mg/dL; Grade 1 Stage 2; Chronic Active Hepatitis due to HBV & HCV Hepatitis Serology ResultHBsAg+; HDV Ab-; HBsAb-; HCV Ab+ (CMIA)
DLS13-15718Hepatitis C (HCV)VietnamPlasma1.0011.00$95.0039 YMAsian< -70C26-Dec-13Roche cobas7,150,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Lopinavir / Ritonavir 200 mg / 50 mgAcquired Infection CategorySexual Transmission SymptomsNo symptomsAdditional TestingALT: 82 U/L; AST: 86 U/L; Serum Creatinine: 90 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS13-15725Hepatitis C (HCV)VietnamPlasma1.0012.00$95.0037 YFAsian< -70C24-Dec-13Roche cobas15,500,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 52 U/L; AST: 44 U/L; Serum Creatinine: 91 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS14-05326Hepatitis C (HCV)VietnamSerum1.009.00$95.0040 YMAsian< -70C02-Jun-14Roche cobas285,000 copies/mL$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 36; AST: 46; Serum Creatinine: 83 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS14-05331Hepatitis C (HCV)VietnamSerum1.0021.00$95.0039 YMAsian< -70C13-Mar-14Roche cobas173,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 85 U/L; AST: 257 U/LHepatitis SerologyAnti HCV+ (Elisa)Co-InfectionsHIV+2013
DLS14-05335Hepatitis C (HCV)VietnamSerum1.008.00$95.0036 YMAsian< -70C17-Jun-14Roche cobas15,800,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 26; AST: 26; Serum Creatinine: 87 umol/LHepatitis SerologyHBsAg+; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS14-05337Hepatitis C (HCV)VietnamSerum1.0011.00$95.0043 YMAsian< -70C28-May-14Roche cobas7,120,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Aluvia 200/50 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 83; AST: 73; Bilirubin: 903 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2005
DLS14-05343Hepatitis C (HCV)VietnamSerum1.0011.00$65.0031 YMAsian< -70C19-Jun-14Roche cobas4,800,000 copies/mLHCV$65.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite Additional TestingALT: 177; AST: 115; Serum Creatinine: 67 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2005
DLS14-05345Hepatitis C (HCV)VietnamSerum1.0010.00$95.0040 YMAsian< -70C14-Mar-14Roche cobas9,000,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg Lamivudine 150 mg Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 102; AST: 130Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS14-05353Hepatitis C (HCV)VietnamSerum1.008.00$65.0054 YMAsian< -70C16-May-14Roche cobas68,200 copies/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Abdominal pain; Sleep disturbances; NauseaAdditional TestingALT: 539; AST: 414; ALP: 141; Bilirubin: 218 umol/L; Serum Creatinine: 0.64 mg/dL
DLS14-05356Hepatitis C (HCV)VietnamSerum1.0012.00$95.0032 YMAsian< -70C28-May-14Roche cobas300,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 50; AST: 46; Serum Creatinine: 77 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2007
DLS14-05392Hepatitis C (HCV)VietnamSerum1.0012.00$65.0047 YFAsian< -70C09-May-14Roche cobas4,660,000 IU/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Jaundice; Sleep disturbances; DepressionAdditional TestingALT: 19; AST: 18; Bilirubin: 7.3 umol/L; Serum Creatinine: 0.6 mg/dL
DLS14-05393Hepatitis C (HCV)VietnamSerum1.008.00$65.0036 YMAsian< -70C08-May-14Roche cobas3,550,000 copies/mLHCV$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg Lamivudine 150 mg Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsNo symptomsAdditional TestingALT: 108; AST: 61Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS14-05354Hepatitis C (HCV)VietnamSerum1.009.00$95.0032 YMAsian< -70C15-Jul-14Roche cobas18,800,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategorySexual TransmissionSymptomsNo symptomsAdditional TestingALT: 178; AST: 121; Serum Creatinine: 77umol/L1-Jul-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)25-Aug-2010Co-InfectionsHIV+16-Aug-10
DLS14-05358Hepatitis C (HCV)VietnamSerum1.0012.00$95.0054 YMAsian< -70C16-Sep-14Roche cobas3,700,000 IU/mL28-Aug-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue; Abdominal painAdditional TestingALT: 28; AST: 63; Bilirubin: 17 umol/L; Serum Creatinine: 1.14 mg/dL12-Sep-14Hepatitis Serology ResultCo-InfectionsTB+2013
DLS14-05360Hepatitis C (HCV)VietnamSerum1.0015.00$65.0066 YFAsian< -70C19-Mar-14Roche cobas950 IU/mL10-Mar-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsAbdominal pain; Joint pain; Sleep disturbancesAdditional TestingALT: 17; AST: 11; Bilirubin: 27 umol/L11-Mar-14Hepatitis Serology Result
DLS14-05386Hepatitis C (HCV)VietnamSerum1.008.00$65.0057 YMAsian< -70C21-Aug-14Roche cobas11,600,000 IU/mL7-May-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; Abdominal pain; JaundiceAdditional TestingALT: 646; AST: 977; Serum Creatinine: 1.02 mg/dL5-Aug-14Hepatitis Serology ResultAnti HCV + (Elisa)5-Aug-2014
DLS14-05405Hepatitis C (HCV)VietnamSerum1.0010.00$65.0066 YMAsian< -70C23-Jul-14Roche cobas16,800 IU/mL9-Jul-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; Abdominal pain; JaundiceAdditional TestingALT: 117; AST: 141; Bilirubin: 72.4 umol/L; Serum Creatinine: 0.8 mg/dL1-Jul-14Hepatitis Serology ResultAnti HCV + Elisa2-Jul-2014
DLS14-08005Hepatitis C (HCV)VietnamSerum1.0012.00$65.0039 YMAsian< -70C06-Nov-14Roche cobas3,570,000 IU/mL1-Nov-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; Jaundice; Flu-like symptomsAdditional TestingALT: 267 U/L; AST: 615 U/L; Bilirubin: 207 umol/L; Serum Creatinine: 0.8 mg/dL29-Oct-14Hepatitis Serology ResultAnti HCV + (Cobas)24-Oct-2014
DLS14-07990Hepatitis C (HCV)VietnamSerum1.0012.00$65.0036 YMAsian< -70C09-Jan-15Roche cobas1,710,000 IU/mL6-Jan-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; Efavirenz Acquired Infection CategoryIV Drug AbuseSymptomsNo symptomsAdditional TestingNoneHepatitis Serology ResultNone
DLS14-07996Hepatitis C (HCV)VietnamSerum1.0016.00$65.0036 YFAsian< -70C30-Jan-15Roche cobas26,700 copies/mLHCV$65.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknownSymptomsNo symptomsAdditional TestingALT: 145 U/L; AST: 57 U/L; Bilirubin: 10.9 umol/L; Serum Creatinine: 63 umol/dL9-Jan-15Hepatitis Serology ResultNone
DLS14-08007Hepatitis C (HCV)VietnamSerum1.006.00$65.0028 YFAsian< -70C14-Nov-14Roche cobas35,400,000 copies/mL7-Nov-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryTransfusionSymptomsFatigueAdditional TestingALT: 52 U/L; AST: 92 U/L; ALP : 92 U/L; Bilirubin: 17 umol/L; Serum Creatinine: 70 umol/L5-Nov-14Hepatitis Serology ResultNone
DLS14-08054Hepatitis C (HCV)VietnamSerum1.0010.00$65.0038 YMAsian< -70C02-Feb-15Roche cobas3,050,000 copies/mL7-Oct-14$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 47 U/L; AST: 62 U/L; Serum Creatinine: 84 umol/dL13-Jan-15Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)28-Oct-2014Co-InfectionsHIV Positive10-Oct-14
DLS14-07992Hepatitis C (HCV)VietnamSerum1.005.00$65.0030 YMAsian<-70°C05-Mar-15Roche cobas1,360 IU/mL4-Mar-15$65.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; JaundiceAdditional TestingALT: 563 U/L; AST: 922 U/L; Bilirubin: 394 umol/L; Serum Creatinine: 79.8 umol/L 12-Feb-15Hepatitis Serology ResultNone
DLS14-08013Hepatitis C (HCV)VietnamSerum1.0014.00$65.0049 YFAsian<-70°C20-Mar-15Roche cobas2,000,000 IU/mL10-Mar-15$65.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; JaundiceAdditional TestingALT: 5 U/L; AST: 35 U/L; Bilirubin: 6.3 umol/L; Serum Creatinine: 48 umol/L 20-Mar-15Hepatitis Serology ResultNone
DLS14-08049Hepatitis C (HCV)VietnamSerum1.0010.00$65.0049 YFAsian<-70°C12-Feb-15Roche cobas5,500,000 copies/mL5-Feb-15$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesAcquired Infection CategorySexual TransmissionSymptomsDecreased Appetite; Fatigue; Abdominal PainAdditional TestingALT: 298 U/L; AST: 135 U/L; Serum Creatinine: 58 umol/L 16-Dec-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)16-Dec-14
DLS15-34152Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0037 YMU/A<-70°C02-Jul-15Roche cobas3,821,825 IU/mLHCV$65.00
DLS15-34153Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0047 YMU/A<-70°C20-Jul-15Roche cobas2,277,300 IU/mLHCV$65.00
DLS15-34155Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0057 YMU/A<-70°C30-Jun-15Roche cobas2,559,498 IU/mLHCV$65.00
DLS15-34156Hepatitis C (HCV)USAK2 EDTA Plasma1.003.00$65.0051 YMU/A<-70°C20-Jul-15Roche cobas1,265,458 IU/mLHCV$65.00
DLS15-34157Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0047 YMU/A<-70°C01-Jul-15Roche cobas3,508,725 IU/mLHCV$65.00
DLS15-34158Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0046 YFU/A<-70°C20-Jul-15Roche cobas820,523 IU/mLHCV$65.00
DLS15-34159Hepatitis C (HCV)USAK2 EDTA Plasma1.003.00$65.0055 YFU/A<-70°C18-Jul-15Roche cobas1,496,422 IU/mLHCV$65.00
DLS15-34160Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0039 YMU/A<-70°C18-Jul-15Roche cobas674,198 IU/mLHCVRoche cobas TaqMan HCV test, v2.0367,240 U/mLHepatitis C Virus RNA Qt 04/08/2019 8:34Roche cobas TaqMan HCV test, v2.05.56 LogUnit/mLHepatitis C Virus RNA Log10 04/08/2019 8:34$65.00
DLS15-34162Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0063 YMU/A<-70°C30-Jun-15Roche cobas194,632 IU/mLHCVRoche cobas TaqMan HCV test, v2.0139,164 U/mLHepatitis C Virus RNA Qt 04/08/2019 8:34Roche cobas TaqMan HCV test, v2.05.14 LogUnit/mLHepatitis C Virus RNA Log10 04/08/2019 8:34$65.00
DLS15-34164Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0061 YFU/A<-70°C01-Jul-15Roche cobas1,101,915 IU/mLHCV$65.00
DLS15-34165Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0041 YFU/A<-70°C17-Jul-15Roche cobas3,142,779 IU/mLHCVRoche cobas TaqMan HCV test, v2.02,081,907 U/mLHepatitis C Virus RNA Qt 04/08/2019 8:34Roche cobas TaqMan HCV test, v2.06.32 LogUnit/mLHepatitis C Virus RNA Log10 04/08/2019 8:34$65.00
DLS15-34167Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0050 YMU/A<-70°C21-Jul-15Roche cobas1,778,924 IU/mLHCV$65.00
DLS15-34168Hepatitis C (HCV)USAK2 EDTA Plasma1.003.00$65.0062 YMU/A<-70°C20-Jul-15Roche cobas1,063,739 IU/mLHCV$65.00
DLS15-34169Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0050 YMU/A<-70°C06-Aug-15Roche cobas2,317,000 IU/mLHCV$65.00
DLS15-34170Hepatitis C (HCV)USAK2 EDTA Plasma1.003.00$65.0057 YFU/A<-70°C06-Aug-15Roche cobas1,444,340 IU/mLHCVRoche cobas TaqMan HCV test, v2.01,259,324 U/mLHepatitis C Virus RNA Qt 04/08/2019 8:34Roche cobas TaqMan HCV test, v2.06.10 LogUnit/mLHepatitis C Virus RNA Log10 04/08/2019 8:34$65.00
DLS15-34171Hepatitis C (HCV)USAK2 EDTA Plasma0.751.00$65.0053 YMU/A<-70°C06-Aug-15Roche cobas340,068 IU/mLHCV$65.00
DLS15-34172Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0067 YMU/A<-70°C06-Aug-15Roche cobas1,678 IU/mLHCV$65.00
DLS15-34174Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0068 YMU/A<-70°C21-Jul-15Roche cobas7,132,610 IU/mLHCV$65.00
DLS15-34175Hepatitis C (HCV)USAK2 EDTA Plasma1.002.00$65.0063 YMU/A<-70°C06-Aug-15Roche cobas2,077,381 IU/mLHCV$65.00
DLS14-12455-PHepatitis C (HCV)USAPlasma1.003.00$45.0041 YMBlack<-70C02-Mar-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesHomosexual M; Intravenous drug user; Body puncturesBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12463-PHepatitis C (HCV)USAPlasma1.007.00$45.0049 YFBlack<-70C09-May-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsWeight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Body punctures (Tattooing); Household contacts of HBV or HCV infected personBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12463-SHepatitis C (HCV)USASerum1.001.00$45.0049 YFBlack<-70C09-May-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsWeight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Body punctures (Tattooing); Household contacts of HBV or HCV infected personBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12470-PHepatitis C (HCV)MexicoPlasma1.006.00$45.0057 YFU/A<-70C01-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsJaundice; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTsRisk CategoriesMultiple sex partners; Transplant / transfusion of unscreened blood or blood products (prior to 1992)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12470-SHepatitis C (HCV)MexicoSerum1.001.00$45.0057 YFU/A<-70C01-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsJaundice; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTsRisk CategoriesMultiple sex partners; Transplant / transfusion of unscreened blood or blood products (prior to 1992)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12474-PHepatitis C (HCV)USAPlasma1.006.00$45.0053 YFBlack<-70C19-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Abdominal pains; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Body punctures (Piercing)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12477-PHepatitis C (HCV)USAPlasma1.006.00$45.0041 YFBlack<-70C10-Sep-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD)'; Intravenous drug user; Body punctures (Tattooing)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12481-PHepatitis C (HCV)USAPlasma1.006.00$45.0042 YFBlack<-70C19-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTsRisk CategoriesOccupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12488-PHepatitis C (HCV)USAPlasma1.004.00$45.0054 YMBlack<-70C23-Aug-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTsRisk CategoriesMultiple sex partnersBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12490-PHepatitis C (HCV)USAPlasma1.006.00$45.0037 YMWhite<-70C13-Sep-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Nausea; Light color feces; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Multiple sex partners; Institutionalized population Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12491-PHepatitis C (HCV)USAPlasma1.006.00$45.0059 YMBlack<-70C17-Sep-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Nausea; Light color feces; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population (Past)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12492-PHepatitis C (HCV)USAPlasma1.007.00$45.0030 YFWhite<-70C09-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Dark color urine; Elevated LFTsRisk CategoriesMultiple sex partners; Body punctures, (Tattooing & piercing); Pregnant (4.5 months)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12494-PHepatitis C (HCV)USAPlasma1.007.00$45.0056 YFBlack<-70C08-Feb-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTsRisk CategoriesOccupational contact with blood (Medical or dental workers); Body punctures (Piercing)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12495-PHepatitis C (HCV)USAPlasma1.006.00$45.0056 YMBlack<-70C29-Jan-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Institutionalized populationBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12495-SHepatitis C (HCV)USASerum1.001.00$45.0056 YMBlack<-70C29-Jan-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Institutionalized populationBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12504-PHepatitis C (HCV)USAPlasma1.007.00$45.0057 YMBlack<-70C15-Nov-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Homosexual M; Body punctures (Human bite); Haemodialysis patientBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12505-PHepatitis C (HCV)USAPlasma1.006.00$45.0045 YFBlack<-70C30-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTsRisk CategoriesBody punctures (Piercing); Household contacts of HBV or HCV infected personBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12505-SHepatitis C (HCV)USASerum1.001.00$45.0045 YFBlack<-70C30-Oct-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTsRisk CategoriesBody punctures (Piercing); Household contacts of HBV or HCV infected personBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12506-PHepatitis C (HCV)USAPlasma1.007.00$45.0053 YFBlack<-70C12-Nov-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Body punctures (Tattooing, piercing); Haemodialysis patientBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12507-PHepatitis C (HCV)USAPlasma1.005.00$45.0061 YMBlack<-70C06-Dec-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Intravenous drug user; Multiple sex partnersBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12509-PHepatitis C (HCV)USAPlasma1.007.00$45.0049 YFBlack<-70C16-Nov-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmited diseases (STD); Body punctures (Piercing); Haemodialysis patientBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12509-SHepatitis C (HCV)USASerum1.001.00$45.0049 YFBlack<-70C16-Nov-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmited diseases (STD); Body punctures (Piercing); Haemodialysis patientBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12513-PHepatitis C (HCV)USAPlasma1.007.00$45.0055 YFBlack<-70C05-Nov-12Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing); Institutionalized populationBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12527-PHepatitis C (HCV)USAPlasma1.005.00$45.0040 YMWhite<-70C12-Aug-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Dark color urine; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Body punctures, (Human bite)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12532-PHepatitis C (HCV)USAPlasma1.006.00$45.0050 YMBlack<-70C02-Apr-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Homosexual M; Multiple sex partners; Transfusion of unscreened blood or blood products (prior to 1992)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12534-PHepatitis C (HCV)USAPlasma1.006.00$45.0044 YMBlack<-70C20-Jun-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12537-PHepatitis C (HCV)USAPlasma1.005.00$45.0057 YMBlack<-70C03-Jun-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesIntravenous drug userBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12539-PHepatitis C (HCV)USAPlasma1.005.00$45.0048 YFBlack<-70C30-Apr-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Vomiting; Abdominal pains; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Body punctures (Piercing, human bite)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12540-PHepatitis C (HCV)MexicoPlasma1.006.00$45.0030 YMU/A<-70C12-Apr-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Elevated LFTsRisk CategoriesIntravenous drug user; Body puncturesBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12550-PHepatitis C (HCV)USAPlasma1.006.00$45.0026 YFWhite<-70C15-May-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsMuscle or joint aches (Myalgia); Elevated LFTsRisk CategoriesTransplant / transfusion of blood or blood products (prior to 1992)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12551-PHepatitis C (HCV)USAPlasma1.006.00$45.0031 YFWhite<-70C03-Jun-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsJaundice; Fatigue; Abdominal pains; Dark color urine; Elevated LFTsRisk CategoriesSexual contacts of HBV or HCV infected person; Body punctures; Household contacts of HBV or HCV infected personBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12552-PHepatitis C (HCV)USAPlasma1.005.00$45.0022 YFWhite<-70C04-Jun-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTsRisk CategoriesIntravenous drug user; Body punctures (Piercing)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12554-PHepatitis C (HCV)USAPlasma1.005.00$45.0046 YMWhite<-70C20-Jun-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsFatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Light color feces (Diarrhea); Elevated LFTsRisk CategoriesIntravenous drug userBio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12558-PHepatitis C (HCV)USAPlasma1.006.00$45.0023 YFBlack<-70C16-Jul-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Multiple sex partners; Body punctures (Tattooing, piercing, human bite)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12566-PHepatitis C (HCV)USAPlasma1.007.00$45.0057 YFBlack<-70C14-Aug-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTsRisk CategoriesBody punctures (Piercing); Transfusion of unscreened blood or blood products (prior to 1992)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12567-PHepatitis C (HCV)USAPlasma1.005.00$45.0057 YFBlack<-70C08-Oct-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Muscle or joint aches (Myalgia); Light color feces; Elevated LFTsRisk CategoriesSexually transmitted diseases (STD); Intravenous drug user; Body punctures; Institutionalized population Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-12573-PHepatitis C (HCV)USAPlasma1.005.00$45.0058 YFBlack<-70C26-Aug-13Ortho HCV 3.0 ELISAReactiveHCV Ab$45.00Signs & SymptomsLoss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTsRisk CategoriesIntravenous drug user; Body punctures (Tattooing, piercing; human bite); Institutionalized population (Prisoner)Bio-Rad GD HBsAg EIA 3.0NegativeMONOLISA Anti-HBC IgM EIANegative
DLS14-07979Hepatitis C (HCV)VietnamSerum1.0010.00$65.0052 YMAsian<-70°C13-May-15Roche cobas97,600 IU/mL4-May-15$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue
DLS14-08000Hepatitis C (HCV)VietnamSerum1.009.00$65.0038 YFAsian<-70°C12-May-15Roche cobas5,050,000 copies/mL26-Apr-15$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue
DLS14-08020Hepatitis C (HCV)VietnamSerum1.006.00$65.0023 YMAsian<-70°C12-May-15Roche cobas5,400 IU/mL8-Mar-15$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Jaundice
DLS14-21266Hepatitis C (HCV)VietnamSerum1.0010.00$65.0048 YMAsian<-70°C27-Nov-15Real-Time PCRUnknownHCV$65.00Signs and SymptomsNo symptoms
DLS16-11777-K2Hepatitis C (HCV)USAK2 EDTA Plasma1.008.00$65.0033 YMWhite<-70C11-Jan-16Abbott PrismPositiveHCV Ab$65.00Roche cobas TaqScreenPositive HCVArlington Scientific Card TestNegativeRPRSmokeYesBlood TypeO+Abbott PrismNegativeHBsAg, Anti-HIV I/IIRoche cobas TaqScreenNegativeHIV, HBV
DLS16-67429Hepatitis C (HCV)VietnamSerum1.0017.00$65.0052 YFAsian<-70°C01-Nov-16Roche cobas11,700 IU/mL26-Oct-16$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 79 U/L; AST: 307 U/L; Bilirubin: 38.6 umol/L; Serum Creatinine: 77 umol/L31-Oct-16Hepatitis SerologyHCV Ab + (cobas 6000E)21-Oct-16Co-InfectionsN/A
DLS16-67466Hepatitis C (HCV)VietnamSerum1.009.00$65.0044 YMAsian<-70°C16-Nov-16Roche cobas1,170,000 IU/mL15-Nov-16$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsAbdominal pain; JaundiceAdditional TestingALT: 26 U/L; AST: 22 U/L13-Nov-16Hepatitis SerologyHCV Ab + (cobas 6000E)Sep-16Co-InfectionsN/A
DLS16-67501Hepatitis C (HCV)VietnamSerum1.0016.00$65.0046 YMAsian<-70°C18-Nov-16Roche HCV Monitor230,000 copies/mL16-Nov-16$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual Transmission SymptomsFatigue; Jaundice; Itching; Sleep disturbancesAdditional TestingALT: 50 U/L; AST: 56 U/L; Serum Creatinine: 86 umol/L9-Jul-16Hepatitis SerologyN/ACo-InfectionsHIV+Jun-05
DLS16-67571Hepatitis C (HCV)VietnamSerum1.0014.00$65.0052 YFAsian<-70°C24-Nov-16Roche HCV Monitor11,700 IU/mL21-Nov-16$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; JaundiceAdditional TestingALT: 833 U/L; AST: 1301 U/L; Bilirubin: 137.8 umol/L; Serum Creatinine: 68 umol/L15-Nov-16Hepatitis SerologyHCV Ab + (cobas 6000E)10-Nov-16Co-InfectionsN/A
DLS16-67611Hepatitis C (HCV)VietnamSerum1.0018.00$65.0054 YMAsian<-70°C24-Nov-16Roche cobas120,000 IU/mL21-Nov-16$65.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 63 U/L; AST: 46 U/L; Bilirubin: 18 umol/L; Serum Creatinine: 83 umol/L21-Nov-16Hepatitis SerologyHCV Ab + (cobas 6000E)21-Nov-16Co-InfectionsN/A
DLS16-67564Hepatitis C (HCV)VietnamSerum1.002.00$65.0039 YMAsian<-70C14-Apr-17Roche Cobas26,000,000 IU/mLHCV Ab$65.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryIV Drug Abuse SymptomsFatigue; JaundiceAdditional TestingALT: 82 U/L, AST: 67 U/L, Bilirubin: 82 umol/L, Serum Creatinine: 72 umol/L, Chronic HCV10-Apr-2017Hepatitis SerologyHCV Ab +Co-InfectionsAIDS+Dec-16
DLS16-67599Hepatitis C (HCV)VietnamSerum1.004.00$65.0054 YMAsian<-70C24-Feb-17Roche Cobas1,490,000 IU/mLHCV Ab$65.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigue; JaundiceAdditional TestingALT: 80 U/L , AST: 118 U/L, Bilirubin: 8 umol/L, Serum Creatinine: 69 umol/L, HCV 201721-Feb-2017Hepatitis SerologyAnti HCV +Co-InfectionsNone
DLS16-67645Hepatitis C (HCV)VietnamSerum1.003.00$65.0036 YMAsian<-70C06-Mar-17Roche Cobas400 IU/mLHCV Ab$65.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 51 U/L, AST: 32 U/L, ALP: 85 U/L, LDH: 150 U/L, Bilirubin: 32.6 umol/L, Chronic HCV 20162-Mar-2017 Hepatitis SerologyNoneCo-InfectionsNone
DLS14-12576Hepatitis C (HCV)USAK2 EDTA5.0024.00$45.00 MU/A<-70C25-Mar-08Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12577Hepatitis C (HCV)USASerum5.0016.00$45.0038 YMWhite<-70C30-Dec-08Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12578Hepatitis C (HCV)USANa25.0032.00$45.0028 YMWhite<-70C08-Apr-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12579Hepatitis C (HCV)USASerum5.0013.00$45.0027 YMHispanic<-70C13-May-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12580Hepatitis C (HCV)USANa Cit5.0030.00$45.0038 YMBlack<-70C18-May-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12581Hepatitis C (HCV)USASerum5.0011.00$45.0033 YFWhite<-70C24-Jun-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12582Hepatitis C (HCV)USASerum5.0028.00$45.00 MU/A<-70C13-Jul-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12583Hepatitis C (HCV)USASerum5.0018.00$45.0018 YMWhite<-70C15-Jul-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12584Hepatitis C (HCV)USASerum5.0013.00$45.00 MU/A<-70C12-Aug-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12585Hepatitis C (HCV)USASerum5.0017.00$45.0036 YMHispanic<-70C30-Jul-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12586Hepatitis C (HCV)USASerum5.0024.00$45.0039 YMBlack<-70C15-Sep-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12587Hepatitis C (HCV)USAK3 EDTA5.0043.00$45.0034 YFBlack<-70C27-Apr-07Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12588Hepatitis C (HCV)USASerum5.0011.00$45.0047 YMBlack<-70C30-Jun-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12589Hepatitis C (HCV)USAK2 EDTA5.0020.00$45.0023 YMWhite<-70C01-Dec-09Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12590Hepatitis C (HCV)USASerum5.009.00$45.0035 YMBlack<-70C01-Dec-09Roche COBAS AmpliScreen HCVPositiveHCV AB$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12591Hepatitis C (HCV)USAK3 EDTA5.0016.00$45.0033 YMWhite<-70C08-Mar-10Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS14-12592Hepatitis C (HCV)USASerum5.0011.00$45.0031 YMWhite<-70C15-Apr-10Roche COBAS AmpliScreen HCVPositiveHCV Ab$45.00Roche cobas TaqScreen MPXReactiveAbbott PRISMNon Reactive
DLS16-67470Hepatitis C (HCV)VietnamSerum1.006.00$65.0032 YMAsian<-70C22-May-17Roche Cobas160,000 IU/mLHCV Ab$65.00Real Time PCRNot Detected22-May-173-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsAbdominal pain; Fatigue; JaundiceAdditional TestingALT: 47 U/L | AST: 62 U/L | Serum Creatinine: 73 umol/L22-May-17Hepatitis SerologyHCV Ab + | COBAS 6000E21-May-2017
DLS16-67462Hepatitis C (HCV)VietnamSerum1.008.00$65.0045 YMAsian<-70C12-May-17Roche Cobas45,000 IU/mLHCV Ab$65.00Real Time PCRNot Detected23-May-173-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsFatigue; Sleep disturbancesAdditional TestingALT: 25 U/L | AST: 32 U/L | Serum Creatinine: 65 umol/L3-May-17Hepatitis SerologyHCV Ab + | COBAS 6000E3-May-2017
KH18-10933Hepatitis C (HCV)USASerum1.501.00$65.0063 YMBlack<-70C13-Feb-18PCRPositiveHCV$65.00RNA4,956, 831
KH18-10934Hepatitis C (HCV)USASerum1.001.00$65.0058 YMWhite<-70C13-Feb-18PCRPositiveHCV$65.00RNA30,320,956
DLS0000101Hepatitis C (HCV)USASerum1.501.00$100.0020 YFU/A<-70C09-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis C$100.00
DLS0002281Hepatitis C (HCV)USASerum1.501.00$100.0039 YFU/A<-70C09-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis C$100.00
DLS0019809Hepatitis C (HCV)USASerum1.501.00$100.0094 YFU/A<-70C08-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.414Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0581N. Gonorrhoeae Not DetectedTreponema pallidum ab U/AC. Trachomatis U/A
DLS0003178Hepatitis C (HCV)USASerum1.251.00$100.0027 YFU/A<-70C08-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative30.1Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative6.12N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
DLS0019903Hepatitis C (HCV)USASerum1.501.00$100.0030 YFU/A<-70C06-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative47.0Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0653N. Gonorrhoeae Not DetectedTreponema pallidum ab U/AC. Trachomatis Not Detected
DLS0002495Hepatitis C (HCV)USASerum1.501.00$100.0028 YFU/A<-70C09-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.139Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0811N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
DLS0020153Hepatitis C (HCV)USASerum1.501.00$100.0038 YFU/A<-70C06-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative14.4Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.132N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/A
DLS0002601Hepatitis C (HCV)USASerum1.501.00$100.0025 YFU/A<-70C06-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.101Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.198N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
DLS0019687Hepatitis C (HCV)USASerum1.501.00$100.0021 YFU/A<-70C07-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative37.3Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative1.15N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
DLS0000372Hepatitis C (HCV)USASerum1.501.00$100.0042 YFU/A<-70C07-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative15.1Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative1.91N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
DLS0002905Hepatitis C (HCV)USASerum1.501.00$100.0051 YMU/A<-70C07-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative44.2Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0954N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not Detected
KH18-12849Hepatitis C (HCV)USASerum1.001.00$65.0054 YMWhite<-70C14-Dec-17PCRPositiveHCV$65.00RNA Quant:7,369,037
KH18-12850Hepatitis C (HCV)USASerum1.751.00$65.0067 YMBlack<-70C19-Feb-18PCRPositiveHCV$65.00RNA Quant:9,282,060
KH18-12851Hepatitis C (HCV)USASerum1.501.00$65.0059 YFBlack<-70C14-Mar-18PCRPositiveHCV$65.00RNA Quant:3,998,420
KH18-12852Hepatitis C (HCV)USASerum1.251.00$65.0033 YFWhite<-70C21-Dec-17PCRPositiveHCV$65.00RNA Quant:3,201,778
KH18-12853Hepatitis C (HCV)USASerum1.001.00$65.0063 YMWhite<-70C28-Dec-17PCRPositiveHCV$65.00RNA Quant:3,256,645
KH18-12854Hepatitis C (HCV)USASerum1.251.00$65.0031 YMAmerican Indian<-70C07-Dec-17PCRPositiveHCV$65.00RNA Quant:493
KH18-12855Hepatitis C (HCV)USASerum1.001.00$65.0059 YMBlack<-70C28-Nov-17PCRPositiveHCV$65.00RNA Quant:1,759,606
KH18-12856Hepatitis C (HCV)USASerum1.001.00$65.0049 YMWhite<-70C28-Nov-17PCRPositiveHCV$65.00RNA Quant:135
KH18-12857Hepatitis C (HCV)USASerum1.001.00$65.0063 YMBlack<-70C29-Nov-17PCRPositiveHCV$65.00RNA Quant:3,068,549
KH18-12858Hepatitis C (HCV)USASerum1.001.00$65.0061 YMBlack<-70C06-Oct-17PCRPositiveHCV$65.00RNA Quant:5,716,504
KH18-12861Hepatitis C (HCV)USASerum1.001.00$65.0050 YMWhite<-70C02-Jul-17PCRPositiveHCV$65.00RNA Quant:935,341
KH18-12865Hepatitis C (HCV)USASerum1.001.00$65.0041 YMWhite<-70C12-Oct-17PCRPositiveHCV$65.00RNA Quant:21,448
KH18-12866Hepatitis C (HCV)USASerum1.001.00$65.0058 YMBlack<-70C07-Sep-17PCRPositiveHCV$65.00RNA Quant:1,210,800
KH18-12868Hepatitis C (HCV)USASerum1.001.00$65.0057 YFBlack<-70C07-Jul-17PCRPositiveHCV$65.00RNA Quant:658,254
KH18-12869Hepatitis C (HCV)USASerum1.001.00$65.0063 YFBlack<-70C31-Oct-17PCRPositiveHCV$65.00RNA Quant:252,621
KH18-12870Hepatitis C (HCV)USASerum1.251.00$65.0034 YFWhite<-70C29-Nov-17PCRPositiveHCV$65.00RNA Quant:2,681
KH18-12871Hepatitis C (HCV)USASerum1.501.00$65.0039 YMBlack<-70C05-Sep-17PCRPositiveHCV$65.00RNA Quant:755,739
KH18-12872Hepatitis C (HCV)USASerum1.501.00$65.0056 YMWhite<-70C05-Sep-17PCRPositiveHCV$65.00RNA Quant:4,.339,277
KH18-12873Hepatitis C (HCV)USASerum1.251.00$65.0052 YMWhite<-70C01-Sep-17PCRPositiveHCV$65.00RNA Quant:242,154
KH18-12875Hepatitis C (HCV)USASerum1.501.00$65.0035 YFWhite<-70C17-Oct-17PCRPositiveHCV$65.00RNA Quant:99,538
KH18-12876Hepatitis C (HCV)USASerum1.001.00$65.0055 YMU/A<-70C12-Sep-17PCRPositiveHCV$65.00RNA Quant:11,225,008
KH18-12877Hepatitis C (HCV)USASerum1.251.00$65.0035 YFWhite<-70C19-Jul-17PCRPositiveHCV$65.00RNA Quant:21,559
KH18-12879Hepatitis C (HCV)USASerum1.501.00$65.0047 YFWhite<-70C30-Jun-17PCRPositiveHCV$65.00RNA Quant:765
KH18-12880Hepatitis C (HCV)USASerum1.251.00$65.0064 YFWhite<-70C06-Jul-17PCRPositiveHCV$65.00RNA Quant:2,102,282
KH18-12881Hepatitis C (HCV)USASerum1.001.00$65.0047 YFU/A<-70C07-Jul-17PCRPositiveHCV$65.00RNA Quant:313,876
KH18-12882Hepatitis C (HCV)USASerum1.001.00$65.0062 YMWhite<-70C22-Sep-17PCRPositiveHCV$65.00RNA Quant:1,165,592
KH18-12883Hepatitis C (HCV)USASerum1.501.00$65.0064 YFBlack<-70C19-Nov-17PCRPositiveHCV$65.00RNA Quant:375,038
KH18-12885Hepatitis C (HCV)USASerum1.251.00$65.0051 YFWhite<-70C13-Nov-17PCRPositiveHCV$65.00RNA Quant:32
KH18-12886Hepatitis C (HCV)USASerum1.251.00$65.0063 YFWhite<-70C06-Jul-17PCRPositiveHCV$65.00RNA Quant:7,951,053
KH18-12887Hepatitis C (HCV)USASerum1.001.00$65.0034 YMBlack<-70C05-Oct-17PCRPositiveHCV$65.00RNA Quant:531,066
KH18-12888Hepatitis C (HCV)USASerum1.001.00$65.0062 YMWhite<-70C13-Jul-17PCRPositiveHCV$65.00RNA Quant:1,691,533
KH18-12889Hepatitis C (HCV)USASerum1.001.00$65.0024 YMWhite<-70C24-Sep-17PCRPositiveHCV$65.00RNA Quant:1,848,790
KH18-12890Hepatitis C (HCV)USASerum1.001.00$65.0064 YMBlack<-70C05-Sep-17PCRPositiveHCV$65.00RNA Quant:3,698,809
KH18-12891Hepatitis C (HCV)USASerum1.001.00$65.0058 YFWhite<-70C14-Oct-17PCRPositiveHCV$65.00RNA Quant:418,462
KH18-12892Hepatitis C (HCV)USASerum1.001.00$65.0056 YMWhite<-70C05-Sep-17PCRPositiveHCV$65.00RNA Quant:4,339,277
KH18-12894Hepatitis C (HCV)USASerum1.001.00$65.0084 YFBlack<-70C06-Jul-17PCRPositiveHCV$65.00RNA Quant:4,918,625
DLS0017731Hepatitis C (HCV)USASerum1.501.00$100.0056 YFU/A<-70C09-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative30.6Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0801N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019211Hepatitis C (HCV)USASerum1.501.00$100.0052 YFU/A<-70C09-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative26.6Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative3.37N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019138Hepatitis C (HCV)USASerum1.501.00$100.0041 YFU/A<-70C15-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative34.6Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.164N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019191Hepatitis C (HCV)USASerum1.501.00$100.0051 YFU/A<-70C15-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative35.5Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.259N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019422Hepatitis C (HCV)USASerum1.001.00$100.0024 YFU/A<-70C15-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.0113Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.110N. Gonorrhoeae U/ATreponema pallidum ab U/AC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019255Hepatitis C (HCV)USASerum1.501.00$100.0024 YFU/A<-70C12-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative5.39Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.138N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0017408Hepatitis C (HCV)USASerum1.501.00$100.0020 YFU/A<-70C12-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative50.5Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative6.86N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019181Hepatitis C (HCV)USASerum1.501.00$100.0016 YFU/A<-70C13-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.0730Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0879N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019050Hepatitis C (HCV)USASerum1.501.00$100.0040 YFU/A<-70C13-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative31.3Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.158N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019803Hepatitis C (HCV)USASerum1.251.00$100.0052 YFU/A<-70C16-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative34.3Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative2.32N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002815Hepatitis C (HCV)USASerum1.001.00$100.0022 YFU/A<-70C16-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.0512Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0729N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0018879Hepatitis C (HCV)USASerum1.501.00$100.0029 YFU/A<-70C16-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative<0.0100Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0532N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002447Hepatitis C (HCV)USASerum1.001.00$100.0029 YFU/A<-70C23-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/A$100.00
DLS0003641Hepatitis C (HCV)USASerum1.501.00$100.0055 YFU/A<-70C23-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/A$100.00
DLS0003285Hepatitis C (HCV)USASerum1.501.00$100.0056 YFU/A<-70C22-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative1.19Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.174N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019697Hepatitis C (HCV)USASerum1.251.00$100.0030 YFU/A<-70C22-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative1.27Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative10.2N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002577Hepatitis C (HCV)USASerum1.001.00$100.0021 YFU/A<-70C19-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative30.9Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative2.02N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0019571Hepatitis C (HCV)USASerum1.251.00$100.0021 YFU/A<-70C19-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.123Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.17N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002851Hepatitis C (HCV)USASerum1.501.00$100.0040 YFU/A<-70C20-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative21.4Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative7.86N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0020187Hepatitis C (HCV)USASerum1.251.00$100.0046 YFU/A<-70C19-Mar-18Roche cobas 602 | ECLIA0.03Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative50.6Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0851N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0003437Hepatitis C (HCV)USASerum1.251.00$100.0054 YMU/A<-70C20-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.135Anti HSV 2 IgGPositiveAnti HSV 2 IgG Quantitative4.11N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboU/A
DLS0000516Hepatitis C (HCV)USASerum1.001.00$100.0017 YFU/A<-70C23-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative1.52Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.220N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002627Hepatitis C (HCV)USASerum1.501.00$100.0066 YFU/A<-70C29-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative41.5Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.579N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0000144Hepatitis C (HCV)USASerum1.001.00$100.0018 YFU/A<-70C28-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.108Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.190N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0002188Hepatitis C (HCV)USASerum1.501.00$100.0034 YMU/A<-70C23-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.0764Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.144N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0003763Hepatitis C (HCV)USASerum1.501.00$100.0039 YFU/A<-70C30-Mar-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative31.1Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.118N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboU/A
DLS0003309Hepatitis C (HCV)USASerum1.501.00$100.0029 YFU/A<-70C06-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGU/A$100.00Anti HSV 1 IgG QuantitativeU/AAnti HSV 2 IgGU/AAnti HSV 2 IgG QuantitativeU/AN. Gonorrhoeae U/ATreponema pallidum ab U/AC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboU/A
DLS0004401Hepatitis C (HCV)USASerum1.501.00$100.0032 YFU/A<-70C05-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis U/AAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative47.8Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0987N. Gonorrhoeae U/ATreponema pallidum ab NegativeC. Trachomatis U/AHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0003673Hepatitis C (HCV)USASerum1.501.00$100.0017 YFU/A<-70C05-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.337Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.26N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0004374Hepatitis C (HCV)USASerum1.251.00$100.0026 YFU/A<-70C05-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGPositive$100.00Anti HSV 1 IgG Quantitative50.1Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.0681N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0004533Hepatitis C (HCV)USASerum1.501.00$100.0021 YFU/A<-70C04-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.177Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.468N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
DLS0004621Hepatitis C (HCV)USASerum1.001.00$100.0029 YFU/A<-70C06-Apr-18Roche cobas 602 | ECLIA0.04Hepatitis CT. Vaginalis Not DetectedAnti HSV 1 IgGNegative$100.00Anti HSV 1 IgG Quantitative0.634Anti HSV 2 IgGNegativeAnti HSV 2 IgG Quantitative0.114N. Gonorrhoeae Not DetectedTreponema pallidum ab NegativeC. Trachomatis Not DetectedHIV 1| 2 Ag|Ab ComboNon Reactive
KH18-37365Hepatitis C (HCV)USASerum1.251.00$65.0016 YFWhite<-70C23-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-37366Hepatitis C (HCV)USASerum1.251.00$65.0017 YFBlack<-70C23-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-37370Hepatitis C (HCV)USASerum1.501.00$65.0017 YFBlack<-70C23-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-36546Hepatitis C (HCV)USASerum1.001.00$65.0016 YFBlack<-70C16-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-36548Hepatitis C (HCV)USASerum1.251.00$65.0016 YFBlack<-70C17-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-36553Hepatitis C (HCV)USASerum1.001.00$65.0016 YFWhite<-70C22-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-36554Hepatitis C (HCV)USASerum1.251.00$65.0015 YFBlack<-70C17-Aug-18Abbott ArchitectNegativeHCV Ab$65.00
KH18-45193Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0065 YFBlack<-70C15-Oct-18Abbott Architect14.21 +HCV Ab$65.00
KH18-45194Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0046 YFAmerican Indian<-70C08-Oct-18Abbott Architect7.25 +HCV Ab$65.00
KH18-53116Hepatitis C (HCV)USASerum1.501.00$65.0054 YFWhite<-70C31-Oct-18Abbott Architect1.35HCV Ab$65.00
KH18-54861Hepatitis C (HCV)USASerum1.751.00$65.0058 YMBlack<-70C02-Nov-18Abbott Architect15.44HCV Ab$65.00
KH18-54862Hepatitis C (HCV)USASerum1.501.00$65.0023 YFWhite<-70C10-Nov-18Abbott Architect12.94HCV Ab$65.00
KH18-54863Hepatitis C (HCV)USASerum1.001.00$65.0050 YFWhite<-70C10-Nov-18Abbott Architect13.77HCV Ab$65.00
KH18-54864Hepatitis C (HCV)USASerum1.001.00$65.0056 YMWhite<-70C11-Nov-18Abbott Architect8.93HCV Ab$65.00
KH18-54865Hepatitis C (HCV)USASerum1.001.00$65.0056 YFBlack<-70C13-Nov-18Abbott Architect11.38HCV Ab$65.00
KH18-54866Hepatitis C (HCV)USASerum1.001.00$65.0055 YFBlack<-70C16-Nov-18Abbott Architect13.97HCV Ab$65.00
KH18-54867Hepatitis C (HCV)USASerum1.001.00$65.0026 YMWhite<-70C13-Nov-18Abbott Architect13.53HCV Ab$65.00
KH18-54868Hepatitis C (HCV)USASerum1.001.00$65.0032 YMU/A<-70C15-Nov-18Abbott Architect14.62HCV Ab$65.00
KH18-54869Hepatitis C (HCV)USASerum1.001.00$65.0033 YMWhite<-70C10-Nov-18Abbott Architect11.29HCV Ab$65.00
KH18-54870Hepatitis C (HCV)USASerum1.001.00$65.0037 YFU/A<-70C05-Nov-18Abbott Architect4.64HCV Ab$65.00
KH18-54871Hepatitis C (HCV)USASerum1.001.00$65.0051 YMWhite<-70C04-Nov-18Abbott Architect6.57HCV Ab$65.00
KH18-54872Hepatitis C (HCV)USASerum1.001.00$65.0064 YMWhite<-70C08-Nov-18Abbott Architect1.04HCV Ab$65.00
KH18-54874Hepatitis C (HCV)USASerum1.001.00$65.0059 YMBlack<-70C15-Nov-18Abbott Architect5.83HCV Ab$65.00
KH18-54875Hepatitis C (HCV)USASerum1.001.00$65.0029 YMWhite<-70C16-Nov-18Abbott Architect14.08HCV Ab$65.00
KH18-54876Hepatitis C (HCV)USASerum1.001.00$65.0027 YFWhite<-70C06-Nov-18Abbott Architect15.09HCV Ab$65.00
KH18-53441Hepatitis C (HCV)USASerum1.501.00$65.0061 YMWhite<-70C14-Nov-18Abbott Architect10.89HCV Ab$65.00
KH18-53442Hepatitis C (HCV)USASerum1.501.00$65.0040 YFWhite<-70C12-Nov-18Abbott Architect5.03HCV Ab$65.00
KH18-53443Hepatitis C (HCV)USASerum1.001.00$65.0057 YMWhite<-70C09-Nov-18Abbott Architect14.49HCV Ab$65.00
KH19-01068Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0056 YMBlack<-70C25-Nov-18Abbott Architect11.87HCV Ab$65.00
KH19-01115Hepatitis C (HCV)USASerum1.001.00$65.0059 YFBlack<-70C29-Nov-18Abbott Architect1.18HCV Ab$65.00
KH19-01116Hepatitis C (HCV)USASerum1.001.00$65.0027 YMWhite<-70C29-Nov-18Abbott Architect2.13HCV Ab$65.00
KH19-01117Hepatitis C (HCV)USASerum1.001.00$65.0032 YMU/A<-70C27-Nov-18Abbott Architect11.59HCV Ab$65.00
KH19-01118Hepatitis C (HCV)USASerum1.001.00$65.0031 YMWhite<-70C27-Nov-18Abbott Architect14.03HCV Ab$65.00
KH19-01119Hepatitis C (HCV)USASerum1.501.00$65.0068 YFWhite<-70C30-Nov-18Abbott Architect11.72HCV Ab$65.00
KH19-02601Hepatitis C (HCV)USASerum1.251.00$65.0037 YMWhite<-70C11-Dec-18Abbott Architect16.67HCV Ab$65.00
KH19-02602Hepatitis C (HCV)USASerum1.001.00$65.0059 YFWhite<-70C12-Dec-18Abbott Architect13.43HCV Ab$65.00
KH19-02605Hepatitis C (HCV)USASerum1.001.00$65.0069 YMWhite<-70C13-Dec-18Abbott Architect11.12HCV Ab$65.00
KH19-02606Hepatitis C (HCV)USASerum1.501.00$65.0027 YFBlack<-70C13-Dec-18Abbott Architect10.03HCV Ab$65.00
KH19-02608Hepatitis C (HCV)USASerum1.001.00$65.0052 YFWhite<-70C16-Dec-18Abbott Architect12.94HCV Ab$65.00
KH19-02609Hepatitis C (HCV)USASerum1.001.00$65.0031 YMWhite<-70C17-Dec-18Abbott Architect15.75HCV Ab$65.00
KH19-04095Hepatitis C (HCV)USASerum1.251.00$65.0075 YFWhite<-70C20-Dec-18Abbott Architect2.47HCV Ab$65.00
KH19-04096Hepatitis C (HCV)USASerum1.001.00$65.0037 YFWhite<-70C17-Dec-18Abbott Architect18.29HCV Ab$65.00
KH19-03597Hepatitis C (HCV)USASerum1.001.00$65.0048 YFBlack<-70C31-Dec-18Abbott Architect2.8HCV Ab$65.00
KH19-03598Hepatitis C (HCV)USASerum1.001.00$65.0033 YFWhite<-70C04-Jan-19Abbott Architect13.49HCV Ab$65.00
KH19-03599Hepatitis C (HCV)USASerum1.001.00$65.0031 YMWhite<-70C03-Jan-19Abbott Architect14.73HCV Ab$65.00
KH19-03600Hepatitis C (HCV)USASerum1.001.00$65.0027 YMWhite<-70C08-Dec-18Abbott Architect13.55HCV Ab$65.00
KH19-03601Hepatitis C (HCV)USASerum1.001.00$65.0026 YMWhite<-70C02-Jan-19Abbott Architect12.25HCV Ab$65.00
KH19-03856Hepatitis C (HCV)USASerum1.001.00$65.0037 YMU/A<-70C08-Jan-19Abbott Architect11.94HCV Ab$65.00
KH19-03857Hepatitis C (HCV)USASerum1.001.00$65.0044 YMWhite<-70C14-Jan-19Abbott Architect16.58HCV Ab$65.00
KH19-03858Hepatitis C (HCV)USASerum1.001.00$65.0026 YMBlack<-70C10-Jan-19Abbott Architect1.68HCV Ab$65.00
KH19-03859Hepatitis C (HCV)USASerum1.001.00$65.0023 YFU/A<-70C12-Jan-19Abbott Architect14.84HCV Ab$65.00
KH19-03860Hepatitis C (HCV)USASerum1.001.00$65.0022 YMBlack<-70C15-Jan-19Abbott Architect14.46HCV Ab$65.00
KH19-03861Hepatitis C (HCV)USASerum1.501.00$65.0061 YFBlack<-70C10-Jan-19Abbott Architect11.11HCV Ab$65.00
KH19-03862Hepatitis C (HCV)USASerum1.001.00$65.0066 YFBlack<-70C10-Jan-19Abbott Architect13.15HCV Ab$65.00
KH19-03863Hepatitis C (HCV)USASerum1.501.00$65.0070 YMBlack<-70C10-Jan-19Abbott Architect8.44HCV Ab$65.00
KH19-03864Hepatitis C (HCV)USASerum1.001.00$65.0049 YMBlack<-70C10-Jan-19Abbott Architect11.46HCV Ab$65.00
KH19-03865Hepatitis C (HCV)USASerum1.001.00$65.0035 YMWhite<-70C12-Jan-19Abbott Architect14.30HCV Ab$65.00
KH19-03866Hepatitis C (HCV)USASerum1.001.00$65.0040 YFU/A<-70C10-Jan-19Abbott Architect12.65HCV Ab$65.00
KHBR-1584Hepatitis C (HCV)USASerum2.251.00$75.0027 YFWhite<-70C31-Oct-17Abbott ArchitectPositiveHCV$75.00IV Drug UseDate of Freeze01.09.18
KHBR-1737Hepatitis C (HCV)USASerum1.751.00$75.0061 YFWhite<-70C17-Apr-18Roche COBAS | Taqman142,170 IU/mLHCV Viral Load$75.00Date of Freeze05.15.18B19.2
KH19-06085Hepatitis C (HCV)USASerum1.751.00$65.0066 YMU/A<-70C11-Jan-19Abbott Architect13.74HCV Ab$65.00
KH19-06086Hepatitis C (HCV)USASerum1.001.00$65.0034 YFAsian<-70C11-Jan-19Abbott Architect9.58HCV Ab$65.00
KH19-06087Hepatitis C (HCV)USASerum1.501.00$65.0052 YMBlack<-70C11-Jan-19Abbott Architect2.31HCV Ab$65.00
KH19-06088Hepatitis C (HCV)USASerum1.001.00$65.0049 YMBlack<-70C10-Jan-19Abbott Architect1.37HCV Ab$65.00
KH19-06089Hepatitis C (HCV)USASerum1.001.00$65.0026 YFWhite<-70C17-Jan-19Abbott Architect15.39HCV Ab$65.00
KH19-06090Hepatitis C (HCV)USASerum1.001.00$65.0038 YFBlack<-70C17-Jan-19Abbott Architect2.56HCV Ab$65.00
KH19-06091Hepatitis C (HCV)USASerum1.501.00$65.0038 YMU/A<-70C21-Jan-19Abbott Architect12.56HCV Ab$65.00
KH19-06092Hepatitis C (HCV)USASerum1.001.00$65.0040 YMWhite<-70C20-Jan-19Abbott Architect14.51HCV Ab$65.00
KH19-06093Hepatitis C (HCV)USASerum1.501.00$65.0030 YFWhite<-70C20-Jan-19Abbott Architect14.33HCV Ab$65.00
KH19-06094Hepatitis C (HCV)USASerum1.001.00$65.0056 YFBlack<-70C16-Jan-19Abbott Architect15.42HCV Ab$65.00
KH19-06095Hepatitis C (HCV)USASerum1.501.00$65.0061 YMBlack<-70C16-Jan-19Abbott Architect9.48HCV Ab$65.00
KH19-06096Hepatitis C (HCV)USASerum1.001.00$65.0054 YMWhite<-70C16-Jan-19Abbott Architect1.22HCV Ab$65.00
KH19-06097Hepatitis C (HCV)USASerum1.251.00$65.0081 YMBlack<-70C15-Jan-19Abbott Architect10.67HCV Ab$65.00
KH19-06098Hepatitis C (HCV)USASerum1.501.00$65.0060 YMWhite<-70C15-Jan-19Abbott Architect14.33HCV Ab$65.00
KH19-071107Hepatitis C (HCV)USASerum1.001.00$65.0021 YFWhite<-70C26-Jan-19Abbott Architect14.61HCV Ab$65.00
KH19-071108Hepatitis C (HCV)USASerum1.001.00$65.0030 YMWhite<-70C25-Jan-19Abbott Architect13.65HCV Ab$65.00
KH19-071109Hepatitis C (HCV)USASerum1.001.00$65.0047 YMAmerican Indian<-70C28-Jan-19Abbott Architect15.76HCV Ab$65.00
KH19-071110Hepatitis C (HCV)USASerum1.001.00$65.0018 YFWhite<-70C28-Jan-19Abbott Architect14.62HCV Ab$65.00
KH19-071111Hepatitis C (HCV)USASerum1.501.00$65.0058 YMWhite<-70C25-Jan-19Abbott Architect10.88HCV Ab$65.00
KH19-071112Hepatitis C (HCV)USASerum1.501.00$65.0048 YMBlack<-70C24-Jan-19Abbott Architect14.29HCV Ab$65.00
KH19-071113Hepatitis C (HCV)USASerum1.251.00$65.0044 YFBlack<-70C24-Jan-19Abbott Architect1.14HCV Ab$65.00
KH19-071114Hepatitis C (HCV)USASerum1.001.00$65.0068 YMBlack<-70C22-Jan-19Abbott Architect11.19HCV Ab$65.00
KHBR19-00006Hepatitis C (HCV)USASerum1.301.00$65.0031 YFWhite<-70C02-Feb-19Viral Load1,708,323 IU/mLHCV RNA$65.00Freeze Date2/28/2019
KHBR19-00072Hepatitis C (HCV)USASerum1.501.00$65.0065 YMU/A<-70C05-Feb-19Roche COBAS | Taqman8,319,879 IU/mLHCV RNA PCR$65.00Freeze Date05.21.19
DLS0075812Hepatitis C (HCV)USASerum1.251.00$65.0028 YMWhite<-70C21-Jan-19Abbott Architect i20001,182 IU/mLHCV AB$65.00F11.10, H52.03, H53.001, Z97.3, B18.2, S60.552A
KH19-087830Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0019 YFU/A<-70C25-Jun-19Abbott Architect16.23HCV Ab$65.00
KH19-087829Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0051 YMAmerican Indian<-70C25-Jun-19Abbott Architect15.72HCV Ab$65.00
KH19-088450Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0062 YFBlack<-70C16-Jul-19Abbott Architect I2000 | CMIA15.42HCV Ab$65.00
KH19-088451Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0062 YFBlack<-70C15-Jul-19Abbott Architect I2000 | CMIA0.8HCV Ab$65.00
KH19-088910Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0048 YMBlack<-70C23-Jul-19Abbott Architect I2000 | CMIA1.52HCV Ab$65.00
KH19-088911Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0057 YFWhite<-70C05-Jul-19Abbott Architect I2000 | CMIA10.15HCV Ab$65.00
KH19-088912Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0032 YFWhite<-70C05-Jul-19Abbott Architect I2000 | CMIA14.07HCV Ab$65.00
KH19-089401Hepatitis C (HCV)USAK2 EDTA Plasma1.751.00$65.0034 YFWhite<-70C25-Jul-19Abbott Architect I2000 | CMIA12.08HCV Ab$65.00
KH19-089402Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0059 YFWhite<-70C25-Jul-19Abbott Architect I2000 | CMIA10.23HCV Ab$65.00
KH19-091377Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0061 YMBlack<-70C02-Aug-19Abbott Architect I2000 | CMIA14.97HCV Ab$65.00
KH19-091378Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0053 YFBlack<-70C02-Aug-19Abbott Architect I2000 | CMIA2.51HCV Ab$65.00
KH19-091379Hepatitis C (HCV)USAK2 EDTA Plasma1.251.00$65.0032 YFWhite<-70C06-Jul-19Abbott Architect I2000 | CMIA14.07HCV Ab$65.00
KH19-091376Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0053 YMWhite<-70C01-Aug-19Abbott Architect I2000 | CMIA13.39HCV Ab$65.00
KH19-090079Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0047 YFBlack<-70C12-Aug-19Abbott Architect I2000 | CMIA15.91 IU/mLHCV Ab$65.00
KH19-090078Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0054 YMBlack<-70C09-Aug-19Abbott Architect I2000 | CMIA14.07 IU/mLHCV Ab$65.00
KH19-090077Hepatitis C (HCV)USAK2 EDTA Plasma1.501.00$65.0050 YMWhite<-70C06-Aug-19Abbott Architect I2000 | CMIA14.39 IU/mLHCV Ab$65.00
KH19-092096Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0055 YMWhite<-70C14-Aug-19Abbott Architect I2000 | CMIA5.13HCV Ab$65.00
KH19-092097Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0045 YMWhite<-70C17-Aug-19Abbott Architect I2000 | CMIA14.07HCV Ab$65.00
KH19-086492Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0059 YMWhite<-70C23-Aug-19Abbott Architect I2000 | CMIA17.36HCV Ab$65.00
KH19-093753Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0053 YFU/A<-70C29-Aug-19Abbott Architect I2000 | CMIA14.29HCV Ab$65.00
KH19-093751Hepatitis C (HCV)USAK2 EDTA Plasma1.001.00$65.0024 YFWhite<-70C29-Aug-19Abbott Architect I2000 | CMIA15.03HCV Ab$65.00

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.